Avaliação da neoformação óssea em defeitos críticos com o uso de substitutos ósseos derivados de fosfato e do PLGA/rhGH : estudo preliminar em coelhos

Detalhes bibliográficos
Ano de defesa: 2014
Autor(a) principal: Boing, Fernanda lattes
Orientador(a): Pagnoncelli, Rogério Miranda lattes
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Pontifícia Universidade Católica do Rio Grande do Sul
Programa de Pós-Graduação: Programa de Pós-Graduação em Odontologia
Departamento: Faculdade de Odontologia
País: Brasil
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: http://tede2.pucrs.br/tede2/handle/tede/7172
Resumo: Objective: To evaluate the bone formation with different bone substitutes, including a rhGH hormone carrier (Growth Human Hormone Recombined) in an animal model. Materials and Methods: A total of 12 rabbits (from New Zealand), males, young adults (approximately 10 months old) were used. For each group, 6 rabbits were used, being that in each animal, 4 test sites were performed with a 8 mm diameter trephine, completing the total thickness of the skull. The test sites were distributed in: Group I (a: clot, b: autogenous bone triturated, c: PLGA (poly lactic glycolic acid) + rhGH (Growth Human Hormone Recombined), and d: autogenous bone + rhGH); and Group II (a: HA (hydroxyapatite), b: autogenous bone triturated, c: HA / β-TCP (hydroxyapatite / tricalcium phosphate beta), and d: HA / SiO2n (hydroxyapatite / silicium oxide). The animals were sacrificed after 6 weeks and the samples were prepared and stained with HE (hematoxylin and eosin). A descriptive analysis of the samples was performed with OM (optics microscopic). Results: The evaluation showed that in the samples with PLGA and rhGH there was not the complete filling of the sites, although it was observed inflammatory process compatible with existing biomaterials. The bone formation regions presented filled osteocytic gaps in remodeling process, showing mature and viable bone. In relation to the sites with biomaterials (HA, HA/TCP-b e HA/ HA/SiO2n), all of them showed bone formation with biomaterial incorporation. Conclusion: The results of this study demonstrated the viability of different bone substitutes (HA, HA / TCP-β, HA / SiO2n). In addition, bone formation was not observed throughout the test region with the use of the hormone carrier. However, in regions with neoformation, it was verified the presence of mature and viable bone.